Outcomes of maraviroc-based regimens in HIV-infected individuals

被引：0
|
作者：
Douthwaite, S. [1 ]
Collier, L. [1 ]
Pennell, A. [1 ]
Uriel, A. [1 ]
Wilkins, E. [1 ]
机构：
[1] N Manchester Grp Hosp, Manchester, Lancs, England
来源：
HIV MEDICINE | 2011年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：78 / 79
页数：2
相关论文
共 50 条
  • [41] Immunotherapeutic restoration in HIV-infected individuals
    Kim, June Myung
    Han, Sang Hoon
    IMMUNOTHERAPY, 2011, 3 (02) : 247 - 267
  • [42] AUTOREACTIVE CYTOTOXICITY IN HIV-INFECTED INDIVIDUALS
    ISRAELBIET, D
    VENET, A
    BELDJORD, K
    ANDRIEU, JM
    EVEN, P
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1990, 81 (01): : 18 - 24
  • [43] Tuberculous meningitis in HIV-infected individuals
    Vinnard C.
    MacGregor R.R.
    Current HIV/AIDS Reports, 2009, 6 (3) : 139 - 145
  • [44] Late presentation of HIV-infected individuals
    Bottegay, Manuel
    Fluckiger, Ursula
    Hirschel, Bernard
    Furrer, Hansjakob
    ANTIVIRAL THERAPY, 2007, 12 (06) : 841 - 851
  • [45] The use of caspofungin in HIV-infected individuals
    Waters, Laura
    Nelson, Mark
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (06) : 899 - 908
  • [46] Intensification with maraviroc in HIV-infected individuals (with or without liver cirrhosis) with a discordant CD4 response to cART
    Blanco, J.
    Guardo, A.
    Gonzalez-Cordon, A.
    Perez, I
    Mallolas, J.
    Martinez, E.
    Arberas, H.
    Laguno, M.
    Martinez-Rebollart, M.
    Lonca, M.
    Gatell, J.
    Plana, M.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 169 - 169
  • [47] Pharmacokinetics of Maraviroc, Raltegravir, Darunavir, and Etravirine in the Semen of HIV-Infected Men
    Antoniou, Tony
    Hasan, Sumaira
    Loutfy, Mona R.
    Kovacs, Colin
    Brunetta, Jason
    Smith, Graham
    Halpenny, Roberta
    La Porte, Charles
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 62 (02) : E58 - E60
  • [48] Impact of maraviroc on immune restoration in an advanced stage HIV-infected patient
    Sylvie Bregigeon
    Amélie Menard
    Olivia Faucher
    Catherine Tamalet
    Caroline Solas
    Véronique Obry-Roguet
    Isabelle Poizot-Martin
    Retrovirology, 7
  • [49] Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals
    Arab-Alameddine, M.
    Lubomirov, R.
    Fayet-Mello, A.
    Aouri, M.
    Rotger, M.
    Buclin, T.
    Widmer, N.
    Gatri, M.
    Ledergerber, B.
    Rentsch, K.
    Cavassini, M.
    Panchaud, A.
    Guidi, M.
    Telenti, A.
    Decosterd, L. A.
    Csajka, C.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (09) : 2489 - 2498
  • [50] Assessing the risk of adipose tissue mitochondrial toxicity in HIV-infected individuals on contemporary NRTI regimens
    Hammond, E.
    Nolan, D.
    McKinnon, E.
    Pace, C.
    Mallal, S.
    ANTIVIRAL THERAPY, 2006, 11 (07) : L6 - L7
12345